IRVINE, Calif., Feb. 14, 2017 -- InMode welcomes Mr. Shakil Lakhani, Executive Vice President of Sales, North America. Mr. Lakhani has been in the industry for over a decade, bringing a vast amount of experience with him. He began his career in 2006 with one of the largest aesthetic laser companies, Cynosure Inc., as the youngest Territory Manager, and was quickly promoted to Area Sales Manager and Sales Director by 2013. He has experienced rapid growth throughout his career and attributes the majority of his success to his upbringing and support from his family. Mr. Lakhani graduated with a B.A. from the University of Waterloo.
Mr. Tyler Lembke joins the InMode team as Vice President of Sales for the West Region. With more than 11 years of experience in the medical and aesthetic laser industry, Mr. Lembke has held various sales and management positions for Cynosure, Cutera, and Lumenis. Most recently Mr. Lembke has specialized in the introduction and rapid launch of innovative niche technologies into the marketplace. Mr. Lembke graduated with a Bachelor of Science in Business from Oklahoma State University.
Adrian Bishop is appointed as Vice President of Sales for the East Region. Previously, Mr. Bishop served as Director of Sales, Southeast Region for Syneron-Candela. He was the Top Producing Director of Sales for both fiscal year 2015 and fiscal 2016 for Syneron breaking sales records both years. He also held many sales and training roles with Syneron Candela as well as Solta Medical prior to that. Mr. Bishop has a proven track record of building award winning sales teams and will continue that momentum at InMode. Mr. Bishop received a B.S.B.A. in Marketing and Business Administration from Christian Brothers University in Memphis TN.
“InMode is very excited about the growth opportunities brought by our new executive team. Coupled with our outstanding technology, this improved sales structure will further strengthen our presence in the aesthetic market,” says Erik Dowell, CEO of Americas.
About InMode Aesthetics
InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser, and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode/Invasix technologies by visiting www.inmodemd.com.
Contact: Yang Phan Vice-President of Marketing for North America [email protected] | 1.855.411.2639 x3


TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 



